About Us
安肽生醫科技股份有限公司於2018年4月成立於新竹竹北生醫園區,是一家專注於開發新型治療性抗體和蛋白質藥物的新藥研發公司。自2020年7月起,總部則移至台灣新竹科學園區矽導中心。主要使命是為免疫治療和感 […]
Core Technology
ATBM® has constructed antibody libraries and protein libraries with high complexity, and set up a highly efficient platform for protein/antibody production and antibody screening. We focus on developing Neobody™, a new generation multivalent antibody, which enhances the capability of our immune system to detect and destroy tumor cells and avoids attacks on normal cells.